Blockade of Insulin-Like Growth Factor Type-1 Receptor with Cixutumumab (IMC-A12): A Novel Approach to Treatment for Multiple Cancers

Publisher: Bentham Science Publishers

E-ISSN: 1873-5592|12|14|2016-2033

ISSN: 1389-4501

Source: Current Drug Targets, Vol.12, Iss.14, 2011-12, pp. : 2016-2033

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content